Status:
COMPLETED
Urdu Translation, Validity and Reliability of Dyspnea 12 (D-12)
Lead Sponsor:
Riphah International University
Conditions:
COPD
Eligibility:
All Genders
40-65 years
Brief Summary
Dyspnea is a distressing symptom with pain like perception. The object of study is to translate a tool that measure overall dyspnea severity. Although many scales are available to assess dyspnea but D...
Detailed Description
Aim of study is to translate a clinical validate of Urdu version of D-12 in COPDs patients. The study will measure reliability \& validity of dyspnea in Urdu version. No study has been conducted in ou...
Eligibility Criteria
Inclusion
- Patient age between 40-65 with diagnosis of COPD
- Outpatient individual who are on follow up
- Healthy individual
- Those who can read and understand English and Urdu as well.
Exclusion
- Patient with cognitive impairment or sensory disorder were exclude.
- Patient physical disability
- Refuse to perform test
Key Trial Info
Start Date :
August 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 24 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04879095
Start Date
August 13 2020
End Date
April 24 2021
Last Update
June 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Civil Hospital
Hyderābād, Sindh, Pakistan